Scientific Council

Nicole Dale

The AI Bioweapons Risk: We Cannot Afford to Look Away

Abstract visualisation of AI bioweapons risk showing a connected hexagonal network and glowing AI hub, symbolising biosecurity challenges, gene synthesis screening vulnerabilities, biotechnology innovation, and governance in the pharmaceutical industry.

The risk of AI being used to create a bioweapon is a serious concern for pharma biosecurity after researchers found AI-designed toxins can evade DNA screening. Here’s what you need to know about the AI and bioweapons risk.

Nicole Dale

CRO and Vendor Oversight in Clinical Trials

Clinical research professional reviewing operational data and regulatory documents on dual-monitor workstations, illustrating CRO vendor oversight in clinical trials, vendor performance monitoring, compliance management, and quality assurance across outsourced clinical research operations.

ICH E6(R3) raises the governance bar for CRO and vendor oversight in clinical trials. Here's what sponsors must build into outsourcing relationships to protect trial quality and timelines.

Nicole Dale

Ready to Deliver With Continuous Pharmaceutical Manufacturing

High-quality image of automated machinery for continuous pharmaceutical manufacturing with Pharmatica branding.

Continuous pharmaceutical manufacturing cuts production time by up to 90% and is now backed by ICH Q13. Here’s what manufacturing leaders need to know about the shift to CM.